*Work attributed to Department of Pediatric Orthopaedics, Chacha Nehru Bal Chikitsalaya, Geeta Colony, Delhi-110031(India)
This study tested the hypothesis whether the lymphocyte/monocyte ratio (L/M ratio) altered significantly during treatment of paediatric osteoarticular tuberculosis (OATB) for it to be a useful monitor of the response to therapy.
Material and methods
Thirty immunocompetent paediatric patients with OATB treated with 6 months of uninterrupted multidrug anti-tubercular treatment with resultant clinical and radiological healing of the lesion were included. Haemoglobin, total leucocyte, monocyte and lymphocyte count, and erythrocyte sedimentation rate (ESR) were collected at 0, 2 and 6 months, and were analysed.
Results
The L/M ratio altered from high (11) at the start of treatment towards normalisation (9) at 2 months and (7.7) at 6 months. There was no correlation with declining ESR levels.
Conclusions
The L/M ratio may have potential as an effective biomarker response.
AroraANadkarniBDevGChattopadhyaDJainAKTuliSM. The use of immunomodulators as an adjunct to antituberculous chemotherapy in non-responsive patients with osteo-articular tuberculosis. J Bone Joint Surg Br2006; 88: 264–269.
CamposOP. Bone and joint tuberculosis and its treatment. J Bone Joint Surg Am1955; 37: 937–966.
5.
ReillyWA. The behavior of the monocytes in tuberculosis in children. Am Rev Tuberc1932; 25: 178–185.
6.
MedlarEM. An evaluation of the leukocytic reaction in the blood as found in cases of tuberculosis. Am Rev Tuberc1929; 20: 312–346.
7.
CunninghamRSSabinFRSugiyamaSKindwallJA. The role of the monocyte in tuberculosis. Bull Johns Hopkins Hosp1925; 37: 231–280.
8.
SabinFRDoanCACunninghamRS. Studies of the blood in experimental tuberculosis: the monocyte-lymphocyte ratio; the anemia-leucopenia phase. Trans 22nd Annu Meeting Natl Tuberc Assoc1926; 22: 252–256.
9.
BlackfanKDDiamondLK. Monocyte in active tuberculosis: Supravital studies of the blood. Am J Dis Child1929; 37: 233–243.
10.
Ambrose McGeeW. The testing of activity of childhood tuberculosis. Relative value of the Schilling Differential count, the sedimentation rate and the lymphocyte monocyte ratio. J Am Med Assoc1938; 110: 718–722.
11.
HamilBM. Tuberculosis in infants and children. White blood cell counts; evaluation of the monocyte lymphocyte ratio by the supravital staining method. Am J Dis Child1931; 41: 1023–1053.
12.
FlinnJWFlinnRS. The leucocytic picture of the blood as an aid in the prognosis and treatment of pulmonary tuberculosis. Am Rev Tuberc1929; 20: 347–357.
13.
RogersPM. A study of the blood monocytes in children with tuberculosis. N Engl J Med1928; 198: 740–749.
14.
CrenshawAHTuberculosis. In: CrenshawAH (ed). Campbell’s Operative Orthopaedics, 4th ed. St Louis, MO: Mosby, 1963, pp. 942–972.
15.
CarpenterEFrayLGormleyE. Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytes. Immunol Cell Biol1997; 75: 554–560.
16.
DenisMWedlockDNBuddleBM. Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages. Cell Immunol2004; 232: 1–8.
17.
TobinDMRocaFJOhSFMcFarlandRVickeryTWRayJP. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell2012; 148: 434–446.
18.
CasadevallAPirofskiLA. The damage-response framework of microbial pathogenesis. Nat Rev Microbiol2003; 1: 17–24.
19.
NaranbhaiVHillAVAbdool KarimSSNaidooKAbdool KarimQWarimweGM. Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy. J Infect Dis2014; 209: 500–509.
20.
DoanCASabinFR. The relation of the tubercle and the monocyte: lymphocte ratio to resistance and susceptibility in tuberculosis. J Exp Med1930; 52: 113–152.
21.
Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med2000; 161: 1376–1395.
